Viewing Study NCT02242266


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-22 @ 7:22 PM
Study NCT ID: NCT02242266
Status: COMPLETED
Last Update Posted: 2023-12-01
First Post: 2014-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07-28
Start Date Type: ACTUAL
Primary Completion Date: 2006-06-04
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2014-09-16
First Submit QC Date: None
Study First Post Date: 2014-09-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-30
Last Update Post Date: 2023-12-01
Last Update Post Date Type: ACTUAL